Human BAT5 (ABHD16A) activation kit by CRISPRa

CAT#: GA105358

ABHD16A CRISPRa kit - CRISPR gene activation of human abhydrolase domain containing 16A



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-ABHD16A Antibody
    • 50 ug

CNY 4,628.00


ABHD16A (Myc-DDK-tagged)-Human abhydrolase domain containing 16A (ABHD16A), transcript variant 1
    • 10 ug

CNY 6,648.00


ABHD16A rabbit polyclonal antibody
    • 25 ul

CNY 800.00
CNY 1,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol ABHD16A
Locus ID 7920
Kit Components

GA105358G1, BAT5 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA105358G2, BAT5 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA105358G3, BAT5 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001177515, NM_021160, NR_033488, NR_033489
Synonyms BAT5; D6S82E; NG26; PP199
Summary A cluster of genes, BAT1-BAT5, has been localized in the vicinity of the genes for tumor necrosis factor alpha and tumor necrosis factor beta. These genes are all within the human major histocompatibility complex class III region. The protein encoded by this gene is thought to be involved in some aspects of immunity. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...